跳至主要内容
临床试验/ITMCTR2000003657
ITMCTR2000003657尚未招募1 期

Clinical study of Shugan Hewei granule in the treatment of refractory gastroesophageal reflux disease

Yueyang Hospital of Integrated Traditioanl Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 70(—)
性别
All

入选标准

  • A. It was in accordance with the diagnostic criteria of qi stagnation and phlegm resistance type of acid vomiting (gastroesophageal reflux disease).
  • B. Before this study, patients with gastroesophageal reflux disease (GERD) were treated with standard dose PPI for four weeks or more.
  • C. The age is 18-70 years old, with no gender limit.

排除标准

  • A. Patients with one of the following diseases: peptic ulcer, history of gastroesophageal and duodenal surgery, Zhuo AI syndrome, primary esophageal motility disorders (such as achalasia, scleroderma, primary esophageal spasm), malignant lesions of upper gastrointestinal tract, coronary heart disease, diabetes, drug-induced esophagitis, and psychotic patients.
  • B. Pregnant women and allergic constitution patients.
  • C. The patient himself is the researcher directly involved in this clinical study.

研究者

发起方
Yueyang Hospital of Integrated Traditioanl Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine

相似试验

Clinical study of Shugan Hewei granule in the... | 临床试验